- Abnormal cardiac actions may result in irregular heartbeats.
- Continuous innovations along with groundbreaking technological advancements are anticipated to present new opportunities.
- Poor reimbursement structure, global economic downturn, limited availability of resources and lack of skilled technicians will inhibit market growth.
Cardiac rhythm management is the process of monitoring proper heart function using advanced medical devices. Cardiac rhythm management offers various therapeutic solutions to patients suffering from cardiac ailments such as cardiac arrests, cardiac arrhythmias, and heart failure.
Factors such as advancement in medical technology and higher deaths rates from heart ailments and rising global geriatric population are expected to favor the global cardiac rhythm management market. In the US, heart ailments claim a massive number of deaths.
Smoking, excessive consumption of alcohol, obesity and high cholesterol levels are the primary reasons behind heat ailments. Cardiac rhythm management can be conducted by using two particular devices namely implantable cardiac rhythm and pacemakers devices.
Substantial economic growth in developing countries like China and India is anticipated to boost the cardiac rhythm management market in Asia Pacific.
Moreover, continuous innovations along with groundbreaking technological advancements such as the development of MRI pacemakers, miniaturization, power extension, biocompatible materials and increasing cases of cardiovascular attacks such as stroke, high blood pressure and arrhythmia are anticipated to present new opportunities for leading players in the global market.
More acquisitions and mergers, increasing the number of strategic partnerships and collaborations among players and rapid launching of newer products are some of the key trends observed in global cardiac rhythm management market.
A growing prevalence of cardiovascular ailments, rise in life expectancy, increasing heath awareness among people worldwide, and favorable government initiatives are anticipated to influence market growth. A rise in per-capita healthcare expenditure and development of enhanced treatment procedures are additional factors expected to further propel market growth in the near future.
On the other hand, poor reimbursement structure, global economic downturn, limited availability of resources and lack of skilled technicians for operating cardiac rhythm management devices are major factors expected to inhibit growth of the global cardiac rhythm management market.
Buy Research Report: Mobile Water Treatment Systems Market Set to Grow US$ 1,952.0 Mn during 2020-2030
Buy Research Report: Electric Trolling Motors Market to Expand at a CAGR of 3.2% During 2020-2030
Buy Research Report: Global Solar Cells and Modules Market Strategic Assessment and Forecast by 2026
Buy Research Report: What Are the Upcoming Trends in the Telemonitoring System Market? What Impact Would They Make in Forecast – 2026?
Buy Research Report: Global Peak Flow Meter Market Latest Trend Analysis, Progression Status, Revenue Expectation to 2026
On the basis of devices, the global cardiac rhythm management market has been segmented into pacemakers, cardiac resynchronization, external defibrillators, defibrillators, and implantable defibrillators. By end user, the global cardiac rhythm management market has been segmented into home/ambulatory, hospitals, and others.
On the basis of region, the global cardiac rhythm management market has been segmented into North America, Europe, Asia Pacific (APAC), and Latin America.
North America is expected to hold the market pole position. Existence of advanced healthcare infrastructure, favorable government policy, increasing incidences of cardiac diseases, higher number of deaths by cardiovascular disorders, and rising per capita healthcare expenditure is propelling the growth of the market in the region. North America is followed by Europe.
Whereas, the market in APAC is anticipated to witness the fastest growth rate over the next few years. This is primarily attributed to the increasing disposable income, higher incidences of cardiovascular ailments growing awareness about heart ailments and their treatments and development of the healthcare infrastructure in the region.
Key players identified in the global cardiac rhythm management market include Abbott Laboratories, St. Jude Medical, Sorin, Mentice AB, GE Healthcare, Guidant, ELA Medical, Medtronic, Boston Scientific, Altera, Biotronik, Philips Healthcare, and 3M pharmaceuticals.